Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of SDI-118 in Participants in Remission From Depression
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Syndesi Therapeutics
- Registration Number
- NCT05212116
- Locations
- 🇬🇧
University of Manchester, Manchester, Lancashire, United Kingdom
🇬🇧University of Oxford, Oxford, Oxfordshire, United Kingdom
🇬🇧Cardiff University, Cardiff, Wales, United Kingdom
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SDI-118 in Elderly Male and Female Study Participants With Cognitive Decline
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Syndesi Therapeutics
- Target Recruit Count
- 5
- Registration Number
- NCT05199142
- Locations
- 🇩🇪
University Hospital Frankfurt, Frankfurt am Main, Germany
🇬🇧St Pancras Clinical Research, London, United Kingdom
News
No news found